Frigate Ventures »

Summit Therapeutics shares owned by Frigate Ventures

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.3M 942k 7.80

More positions owned by Frigate Ventures

Gildan Activewear Equity (GIL)
iShares Bitcoin Trust Exchange Traded Fund (IBIT)
Invesco QQQ Trust Series 1 Option Put Option (QQQ)
AdvisorShares Pure US Cannabis ETF Exchange Traded Fund (MSOS)
Nano Dimension Adr (NNDM)
Twilio Equity (TWLO)
Hess Corp Equity (HES)
Match Group Equity (MTCH)
Blockchain Coinvestors Acquisition Corp I Warrant (BCSAW)
Clear Channel Outdoor Holdings Option Call Option (CCO)
Globalstar Equity (GSAT)
Lovesac Co/the Equity (LOVE)
Toronto-Dominion Bank/The Option Call Option (TD)
Vivid Seats Equity (SEAT)
Cenovus Energy Equity (CVE)

View all positions for Frigate Ventures

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
T. Rowe Price Associates
Millennium Management
Caption Management
Northern Trust
Balyasny Asset Management
Frigate Ventures
Charles Schwab Investment Management
Susquehanna International
Rafferty Asset Management

View all funds holding Summit Therapeutics